Connection

Carl Atkinson to Immunoconjugates

Back to Details
This is a "connection" page, showing publications Carl Atkinson has written about Immunoconjugates.
Carl Atkinson
Connection Strength
0.024
Immunoconjugates
  1. A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. Blood. 2012 Jun 21; 119(25):6043-51.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.